The purpose of this guideline is to maximise the safety of patients who need haemopoietic stem cell transplantation and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for transplantation to patient needs if services become lim...
To develop an evidence-based clinical practice guideline for the prevention of oral mucositis in children (0-18 years) receiving treatment for cancer or undergoing haematopoietic stem cell transplantation (HSCT).
The Mucositis Prevention Guideline Development Group was interdisciplinary and included in...
A review of the British Society for Histocompatibility and Immunogenetics (BSHI) "Guideline for selection and HLA matching of related, adult unrelated donors and umbilical cord units for haematopoietic progenitor cell transplantation" was undertaken by a BSHI appointed writing committee. Literature searc...
Lehrnbecher, T;
Phillips, R;
Alexander, S;
Alvaro, F;
Carlesse, F;
Fisher, B;
Hakim, H;
Santolaya, M;
Castagnola, E;
Davis, B. L;
Dupuis, L. L;
Gibson, F;
Groll, A. H;
Gaur, A;
Gupta, A;
Kebudi, R;
Petrilli, S. L;
Steinbach, W. J;
Villarroel, M;
Zaoutis, T Sung.
To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient...
Zinzani, Pier Luigi;
Marchetti, Monia;
Billio, Atto;
Barosi, Giovanni;
Carella, Angelo Michele;
Lazzarino, Mario;
Martelli, Maurizio;
Rambaldi, Alessandro;
Rigacci, Luigi;
Tarella, Corrado;
Vitolo, Umberto;
Tura, Sante.
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...
Anticuerpos Monoclonales,
Anticuerpos,
Anticuerpos Monoclonales de Origen Murino/uso terapéutico,
Antineoplásicos,
Esquema de Medicación,
Trasplante de Células Madre Hematopoyéticas,
Linfoma Folicular/patología,
Linfoma/terapia,
Estadificación de Neoplasias,
Rituximab,
Factores de Tiempo
